UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Advances in immunotherapy for hepatocellular carcinoma

Nature reviews. Gastroenterology & hepatology, 2021-08, Vol.18 (8), p.525

2021

Volltextzugriff (PDF)

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

Cell reports (Cambridge), 2017-08, Vol.20 (8), p.1818-1829

2017

Volltextzugriff (PDF)

Expansion of Tumor-Infiltrating CD8 + T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13), p.3672-3684

2017

Volltextzugriff (PDF)

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2303799-2303799

2024

Volltextzugriff (PDF)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2022

2022

Volltextzugriff (PDF)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

Cancers, 2021-06, Vol.13 (13), p.3248

2021

Volltextzugriff (PDF)

The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1 + tumour-infiltrating lymphocytes

British journal of cancer, 2021-03, Vol.124 (6), p.1138-1149

2021

Volltextzugriff (PDF)

Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy

Journal of hepatology, 2022-09, Vol.77 (3), p.593-595

2022

Volltextzugriff (PDF)

Mutated trimeric RBD vaccines: a platform against variants of concern

Signal transduction and targeted therapy, 2023-04, Vol.8 (1), p.161-161, Article 161

2023

Volltextzugriff (PDF)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Frontiers in immunology, 2023-01, Vol.13, p.1044025-1044025

2023

Volltextzugriff (PDF)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Frontiers in immunology, 2022-11, Vol.13, p.985886-985886

2022

Volltextzugriff (PDF)

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

Liver transplantation, 2013-09, Vol.19 (9), p.937-944

2013

Volltextzugriff (PDF)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Frontiers in immunology, 2023-03, Vol.14, p.1172427-1172427

2023

Volltextzugriff (PDF)

Dendritic Cells in Cancer Immunology and Immunotherapy

Cancers, 2024-02, Vol.16 (5), p.981

2024

Volltextzugriff (PDF)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Frontiers in immunology, 2022-10, Vol.13, p.991311-991311

2022

Volltextzugriff (PDF)

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma

Cancers, 2020-11, Vol.12 (11), p.3397

2020

Volltextzugriff (PDF)

Genetic Modification of CD8 + T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies

Frontiers in immunology, 2019-12, Vol.10, p.2990-2990

2019

Volltextzugriff (PDF)

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (3), p.812-821

2011

Volltextzugriff (PDF)

Neoantigens as potential vaccines in hepatocellular carcinoma

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003978

2022

Volltextzugriff (PDF)

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (18), p.7684-7691

2008

Volltextzugriff (PDF)

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

Emerging microbes & infections, 2021-01, Vol.10 (1), p.1931-1946

2021

Volltextzugriff (PDF)

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

Oncoimmunology, 2018-04, Vol.7 (4), p.e1409321-e1409321

2018

Volltextzugriff (PDF)

Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice

Frontiers in immunology, 2018-01, Vol.9, p.68-68

2018

Volltextzugriff (PDF)

Advancing with cancer immunotherapeutics: CD29 + regulatory T cell antagonism

Gut, 2023-10, Vol.73 (3), p.391

2023

Volltextzugriff (PDF)

Tim-3 expression in tumour-associated macrophages: a new player in HCC progression

Gut, 2015-10, Vol.64 (10), p.1502-1503

2015

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(142)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(102)
Humans
(69)
Animals
(62)
Mice
(54)
Immunology
(47)
Biological And Medical Sciences
(42)
Female
(40)
Medical Sciences
(33)
Oncology
(29)
Immunotherapy
(25)
Tumors
(24)
Mice, Inbred C57bl
(22)
Gastroenterology & Hepatology
(20)
Mice, Inbred Balb C
(18)
Cell Line
(16)
Infectious Diseases
(16)
T-Lymphocytes, Cytotoxic - Immunology
(16)
Amino Acid Sequence
(15)
Antigens
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Advances in immunotherapy for hepatocellular carcinoma

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

Expansion of Tumor-Infiltrating CD8 + T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1 + tumour-infiltrating lymphocytes

Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy

Mutated trimeric RBD vaccines: a platform against variants of concern

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Dendritic Cells in Cancer Immunology and Immunotherapy

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma

Genetic Modification of CD8 + T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Neoantigens as potential vaccines in hepatocellular carcinoma

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice

Advancing with cancer immunotherapeutics: CD29 + regulatory T cell antagonism

Tim-3 expression in tumour-associated macrophages: a new player in HCC progression

Suchergebnisse filtern